Brief: Dicot Pharma Says Board Intends To Resolve On Rights Issue Of Approximately SEK 125 Mln
30/06/2024 17:39
June 30 (Reuters) - Dicot Pharma AB DICOT.TE :
* THE BOARD OF DIRECTORS OF DICOT PHARMA INTENDS TO RESOLVE
ON A
RIGHTS ISSUE OF APPROXIMATELY SEK 125 MILLION
* COMPANY CAN RECEIVE ADDITIONAL PROCEEDS FROM WARRANTS
ISSUED AS
PART OF UNITS
Source text for Eikon: ID:nWkr85QX0c
Further company coverage: DICOT.TE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dicot Pharma AB
See all newsBrief: Dicot Pharma Q2 Net Sales Sek 0.0 Million
Brief: Dicot Pharma Submits CTA In EU For Phase 2b Study Of LIB-01
Brief: Dicot Pharma Recruits Cecilia Driving As CFO
Brief: Dicot Pharma Gets FDA Clearance To Start First Part Of Phase 2B Study With Lib-01 In U.S.
Brief: Dicot Pharma Announces Outcome In Oversubscribed Rights Issue